· Periodic Report
Q3 operating profit KRW 15.5 billion, up 74.5% from a year earlier
Medytox sold KRW 59.3 billion in Q3 and made KRW 15.5 billion from its main business, up 74.5% from a year earlier and up 226.0% from the prior quarter.
Medy-Tox Inc. Disclosures
086900 · KOSDAQ · Based on DART filings
Disclosures
2 total · 20 per page
· Preliminary EarningsMajor
Q3 consolidated operating profit KRW 15.5 billion, up 74.5% year on year
Q3 consolidated revenue was KRW 59.3 billion, down 2.8% year on year and 13.7% from Q2, while operating profit was KRW 15.5 billion, up 74.5% year on year.
Catch the next disclosure fast
Get app alerts for new disclosures from Medy-Tox Inc..